Raab & Moskowitz Asset Management LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Raab & Moskowitz Asset Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,233 shares of the healthcare conglomerate’s stock after selling 135 shares during the period. UnitedHealth Group makes up approximately 1.4% of Raab & Moskowitz Asset Management LLC’s portfolio, making the stock its 19th biggest holding. Raab & Moskowitz Asset Management LLC’s holdings in UnitedHealth Group were worth $4,334,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Verdence Capital Advisors LLC boosted its position in UnitedHealth Group by 2.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after purchasing an additional 342 shares during the period. Ascension Capital Advisors Inc. bought a new stake in UnitedHealth Group during the 3rd quarter valued at $216,000. Bellecapital International Ltd. boosted its holdings in shares of UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the period. Great Valley Advisor Group Inc. lifted its holdings in UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after purchasing an additional 1,884 shares in the last quarter. Finally, Rise Advisors LLC grew its holdings in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after buying an additional 163 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock opened at $495.35 on Friday. The stock has a market capitalization of $455.76 billion, a PE ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The business has a 50-day moving average of $485.84 and a 200 day moving average of $514.14. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.26 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on UNH shares. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a research note on Thursday, April 4th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $570.05.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.